Clinical Trial Update: Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating a two-dose schedule of the quadrivalent HPV recombinant vaccine in 11-year-old boys in Mexico City.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Genital Warts
• Human Papillomavirus Infection
• Oropharyngeal Cancer
• Penile Cancer

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Universidad Nacional Autonoma de Mexico | Conditions: Human Papilloma Virus | Phase 3 | Status: UNKNOWN